Although, no difference in N-cadherin were found within oncostreams and the surrounding areas, N-cadherin was elevated in TCGA-GBM (Grade IV) tumors compared to TCGA-LGG (Grade III and II). This evidence concerns the gene CDH2 and glioblastoma.